Pharming Group NV (OTCMKTS:PHGUF – Get Free Report)’s share price hit a new 52-week low on Thursday . The company traded as low as $1.10 and last traded at $1.10, with a volume of 5000 shares changing hands. The stock had previously closed at $1.15.
Pharming Group Stock Down 4.3%
The firm’s 50-day moving average is $1.25 and its two-hundred day moving average is $1.48. The company has a debt-to-equity ratio of 0.40, a quick ratio of 2.06 and a current ratio of 2.63. The stock has a market cap of $738.18 million, a P/E ratio of 91.67 and a beta of 0.46.
Pharming Group Company Profile
Pharming Group NV is a Netherlands-based biopharmaceutical company specializing in the development and commercialization of protein replacement therapies for rare diseases. Founded in 1988 and headquartered in Leiden, the company leverages transgenic technology to produce recombinant proteins, with its flagship product RUCONEST (recombinant C1 esterase inhibitor) indicated for the treatment of acute hereditary angioedema (HAE) attacks. RUCONEST is approved and marketed in the United States, Europe and several other territories through partnerships with leading specialty pharmaceutical companies.
Beyond RUCONEST, Pharming maintains a diversified pipeline targeting unmet needs in rare and ultra-rare disorders.
Featured Stories
- Five stocks we like better than Pharming Group
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
- Lumentum Just Delivered the AI Growth Investors Wanted
- Ryman Checks Into a $1.38B Hospitality Upgrade
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
